The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction

Creative Commons License

Paitazoglou C., ÖZDEMİR R., Pfister R., Bergmann M. W., Bartunek J., KILIÇ T., ...Daha Fazla

EUROINTERVENTION, cilt.15, sa.5, ss.403-410, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 15 Sayı: 5
  • Basım Tarihi: 2019
  • Doi Numarası: 10.4244/eij-d-19-00342
  • Dergi Adı: EUROINTERVENTION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.403-410
  • Kocaeli Üniversitesi Adresli: Evet

Özet

Aims: Reducing elevated left atrial pressure with an atrial septum shunt device is a possible treatment option in symptomatic heart failure patients. This study aimed to investigate the safety and feasibility of the Atrial Flow Regulator (AFR) in heart failure patients.